Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Perspective Therapeutics (CATX) Other financing activities (2023)

Perspective Therapeutics' Other financing activities history spans 2 years, with the latest figure at $65000.0 for Q1 2023.

  • For Q1 2023, Other financing activities changed N/A year-over-year to $65000.0; the TTM value through Dec 2023 reached $65000.0, changed N/A, while the annual FY2023 figure was $65000.0, N/A changed from the prior year.
  • Other financing activities for Q1 2023 was $65000.0 at Perspective Therapeutics, up from $5216.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $65000.0 in Q1 2023 and bottomed at $65000.0 in Q1 2023.